首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >A simple blood microdialysis in freely-moving rats for pharmacokinetic-pharmacodynamic modeling study of Shengmai injection with simultaneous determination of drug concentrations and efficacy levels in dialysate
【24h】

A simple blood microdialysis in freely-moving rats for pharmacokinetic-pharmacodynamic modeling study of Shengmai injection with simultaneous determination of drug concentrations and efficacy levels in dialysate

机译:一种简单的血微透过大鼠,用于盛迈注射药代动力学 - 药物动力学建模研究,同时测定透析液中药物浓度和功效水平的测定

获取原文
获取原文并翻译 | 示例
           

摘要

Microdialysis is a powerful in vivo sampling technique for pharmacokinetic-pharmacodynamic (PK-PD) modeling of drugs in pre-clinical and clinical studies. However, the noticeable limitations of previous studies using microdialysis were that animals anesthesia in the whole experiment and the combination of microdialysis and blood sampling for drug and (or) effect detection, which can obviously influence PK and PD behavior of drugs. In this study, a simple blood microdialysis sampling system in freely moving rats was established for simultaneous study of PK and PD of Shengmai injection (SMI) effect on inducing real-time nitric oxide (NO) release on isoproterenol (ISO) induced myocardial ischemia rats. The LC-MS/MS and HPLC with fluorescence detection (HPLC-FLD) methods were developed to determine ginsenside Rg1, Rg2, Re, Rf, Rb1, Rd and Rc, the main effective components of SMI, and NOx-, the main oxidation products of NO, in dialysates respectively. Through simultaneous determination of drug concentrations and NO efficacy levels in dialysate, the developed methods were successfully applied to set up concentration-time and effect-time profiles followed by PK-PD modeling of SMI effect on inducing NO release after intravenous administration of 10.8 mL kg(-1) SMI in myocardial ischemia rats. The PK-PD modeling characterized the dose-effect relationships of SMI and behaved good prediction ability. The established blood microdialysis in freely-moving rats is an appealing technology for rational PK-PD studies when selecting suitable blood endogenous micromolecule as effect marker. (C) 2018 Elsevier B.V. All rights reserved.
机译:MicrodiaLysis是一种强大的体内采样技术,用于临床前和临床研究中药物药物动力学(PK-PD)模型。然而,使用微透析性的先前研究的明显局限性是在整个实验中麻醉的动物麻醉和微透析和药物采样的组合和(或)效应检测,这可以显然影响药物的PK和PD行为。在这项研究中,建立了一种自由移动大鼠的简单血微透析系统,同时研究了对异丙肾上腺素(ISO)诱导的心肌缺血大鼠进行实时一氧化物(NO)释放的盛迈注射(SMI)对PK和PD的影响。开发了LC-MS / MS和HPLC,具有荧光检测(HPLC-FLD)方法以确定GINSESIDERG1,RG2,RE,RF,RB1,RD和RC,SMI的主要有效成分,以及NOx,主要氧化否,分别在透析液中。通过同时测定药物浓度和在透析液中没有功效水平,成功地应用了开发方法以建立浓度 - 时间和效果 - 时间曲线,然后进行SMI对静脉施用10.8mL kg后诱导释放的PK-PD模型。 (-1)心肌缺血大鼠中的SMI。 PK-PD模型表征了SMI的剂量效应关系和表现良好的预测能力。 The established blood microdialysis in freely-moving rats is an appealing technology for rational PK-PD studies when selecting suitable blood endogenous micromolecule as effect marker. (c)2018年elestvier b.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号